Clinical Trial Update: Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated insulin glargine for improving glucose control in hospitalized patients receiving tube feedings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: University of Pittsburgh | Conditions: Type 2 Diabetes, Hyperglycemia | Phase 4 | Status: COMPLETED